OliX Pharmaceuticals Inc.

In News

Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals - GlobeNewswire

GlobeNewswire - Feb 03, 2026

OliX secures ₩115 billion investment through convertible preferred shares - koreabiomed.com

koreabiomed.com - Aug 20, 2025

OliX and Lilly Enter Global Licensing Agreement for MASH and Other Cardiometabolic Indications - Business Wire

Business Wire - Feb 10, 2025

MASHup: Liver disease brings diverse players to table - BioWorld MedTech

BioWorld MedTech - Dec 24, 2025

Eli Lilly pledges $630m on OliX’s Phase I RNA candidate for MASH - Pharmaceutical Technology

Pharmaceutical Technology - Feb 11, 2025

OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate - Yahoo Finance

Yahoo Finance - Feb 10, 2021

OliX Pharmaceuticals announces positive results of phase 1 study of safety and tolerability of OLX10212 - Modern Retina

Modern Retina - Dec 12, 2023

Eli Lilly inks duo of deals, teaming with AdvanCell, OliX to push deeper into radiopharma, MASH - fiercebiotech.com

fiercebiotech.com - Feb 10, 2025

How OliX Pharmaceuticals is riding the RNAi wave - Pharma Voice

Pharma Voice - Apr 25, 2022

First patient dosed in RNAi therapeutic trial for dry, wet AMD - Eyes On Eyecare

Eyes On Eyecare - Mar 27, 2023

OliX strikes $630 million deal with Lilly for obesity and liver disease drug - koreabiomed.com

koreabiomed.com - Feb 10, 2025

Hansoh Pharma and OliX Pharmaceuticals Enter into Licensing - GlobeNewswire

GlobeNewswire - Oct 12, 2021

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment